Intrinsiqq
Dynavox Group AB logo

Dynavox Group AB Intrinsic Value

DYVOX.XSTO

Compare

Choose a model

Each card values Dynavox Group AB a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

Dynavox Group AB on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.

Years to project

Growth of earnings per share

Earnings per share; starts at its own recent growth

Exit P/E

Starts at the average of its 5-year median P/E, today's and a mature 18

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's earnings per share

    Diluted, last twelve months, as filed

    €0.19

  2. Earnings in 2031

    Grows 20.0% a year for 5 years

    €0.47

  3. Price in 2031

    €0.47 × 30.0 P/E

    €14.20

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    €8.81

  5. Plus dividends

    €0.40 paid over 5 years, discounted the same way

    + €0.29

  6. Fair value

    The most you can pay and still earn 10% a year

    €9.11

  7. Buy below

    Fair value minus your 25% margin of safety

    €6.83

Paying €6.45 instead gives 17.8% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

€9.11

Expected return

17.8% a year

Future price, 2031

€14.20

Buy below

€6.83

Price 29% below fair valuePrice €6.45, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

Dynavox Group AB (DYVOX.XSTO) intrinsic value and fair value

The calculator grows one of Dynavox Group AB's per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for DYVOX.XSTO; this is analysis, not investment advice.

Frequently asked

What is Dynavox Group AB's (DYVOX.XSTO) intrinsic value?+

With Intrinsiqq's starting inputs, Dynavox Group AB's fair value is about €9.11 a share, based on its earnings per share. That assumes earnings per share of €0.19 grows about 20.0% a year for 5 years, the stock then trades at 30.0 times earnings, and you want a 10.0% yearly return. On its other figures: free cash flow €3.64, revenue €11.25. Every input can be changed on the page; the result is a model, not a forecast.

Is Dynavox Group AB overvalued?+

At €6.45, the price is 29% below that fair value of €9.11, and buying at today's price would return about 17.8% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from company filings, not investment advice.

What growth does the Dynavox Group AB valuation assume?+

Earnings per share grows about 20.0% a year to start, its own recent growth per share (three years for a company not yet profitable, five otherwise), capped at 20%. The exit multiple starts at a default.

What is a good margin of safety for Dynavox Group AB?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at €6.83. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Peers

Medical Instruments & Supplies · Pick stocks to compare with DYVOX.XSTO

CompareIntrinsic value
SECARE.XSTOSwedencare AB
€1.78+3.84%61
CAMX.XSTOCamurus AB
kr 742.00+0.47%73
MCAP.XSTOMedCap AB
€49.86+0.32%78
VITR.XSTOVitrolife AB
kr 119.75+1.96%22
BICO.XSTOBICO Group AB
€1.40-5.65%52
BONEX.XSTOBonesupport Holding AB
kr 322.20+0.31%78
SUS.XSTOSurgical Science Sweden AB
kr 56.15+0.81%37
XVIVO.XSTOXVIVO Perfusion AB
kr 199.00-3.40%44

Held by ETFs

DYVOX.XSTO is in 7 US ETFs. The largest of them, with DYVOX.XSTO's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing DYVOX.XSTO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.